Literature DB >> 28698537

Positron emission tomography/computed tomography (PET/CT) and CT for N staging of non-small cell lung cancer.

Sandra Vegar Zubović1, Spomenka Kristić1, Besima Hadžihasanović1.   

Abstract

Aim The aim of this study is to investigate the possibilities of non-invasive diagnostic imaging methods, positron emission tomography/computed tomography (PET/CT) and CT, in clinical N staging of non-small cell lung cancer (NSCLC). Methods Retrospective clinical study included 50 patients with diagnosed NSCLC who have undergone PET/CT for the purpose of disease staging. The International association for the study of lung cancer (IASLC) nodal mapping system was used for analysis of nodal disease. Data regarding CT N-staging and PET/CT Nstaging were recorded. Two methods were compared using χ2 test and Spearman rank correlation coefficient. Results Statistical analysis showed that although there were some differences in determining the N stage between CT and PET/CT, these methods were in significant correlation. CT and PET/CT findings established the same N stage in 74% of the patients. In five patients based on PET/CT findings the staging was changed from operable to inoperable, while in four patients staging was changed from inoperable to operable. Conclusion PET/CT and CT are noninvasive methods that can be reliably used for N staging of NSCLC. Copyright© by the Medical Assotiation of Zenica-Doboj Canton.

Entities:  

Keywords:  lymph nodes; multimodal imaging; pulmonary cancer

Mesh:

Substances:

Year:  2017        PMID: 28698537     DOI: 10.17392/899-17

Source DB:  PubMed          Journal:  Med Glas (Zenica)        ISSN: 1840-0132


  1 in total

1.  Intrapulmonary lymph node metastasis is common in clinically staged IA adenocarcinoma of the lung.

Authors:  DengGuo Zhang; XianChao Chen; Daxin Zhu; Changlong Qin; Jingsi Dong; Xiaoming Qiu; Mingyu Fan; QingHua Zhuo; XiaoJun Tang
Journal:  Thorac Cancer       Date:  2018-11-23       Impact factor: 3.500

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.